Seelos Therapeutics

YTD

ALL

Why Robinhood?

You can watch SEEL and buy or sell other stocks, ETFs, and their options commission-free!

About SEEL

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders.

CEO

Raj Mehra, PhD, MBA

CEORaj Mehra, PhD, MBA

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1987

Founded1987

Employees

—

Employees—

SEEL Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

0.67

Average volume0.67

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.01

52 Week high$0.01

52 Week low

—

52 Week low—

Stock Snapshot

As of today, Seelos Therapeutics(SEEL) shares are valued at $0.84. The company's market cap stands at 100.

On 2026-10-03, Seelos Therapeutics(SEEL) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Seelos Therapeutics(SEEL) stock has reached 0, versus its average volume of 0.67.

People also own

Based on the portfolios of people who own SEEL. This list is generated using Robinhood data, and it’s not a recommendation.

Mind Medicine (MindMed)

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.